Bacterial Phosphorylation Suppresses Carbapenemase Activity of the Class-D β-Lactamase OXA-24/40 from Acinetobacter baumannii

被引:0
|
作者
Rajalingam, Dharshika [1 ]
Piszkin, Luke [1 ]
Rodriguez-Medina, Andrea [1 ]
Peng, Jeffrey W. [1 ]
机构
[1] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA
关键词
CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CHEMICAL-SHIFTS; INHIBITION; N-15; H-1;
D O I
10.1021/jacs.4c11321
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The resistance of Gram-negative bacteria to beta-lactam antibiotics is mostly due to deactivation of the antibiotics by bacterial enzymes, beta-lactamases. Disclosing the factors regulating beta-lactamase activity is vital for developing therapies to combat multidrug-resistant pathogens, such as Acinetobacter baumannii. Recent A. baumannii studies have revealed post-translational phosphorylation of serine beta-lactamases at the active site serine. However, the functional consequences of such phosphorylation are unclear. We have taken the first steps to define these consequences through studies of OXA-24/40, a carbapenem-hydrolyzing class D beta-lactamase in A. baumannii. We generated OXA-24/40 phosphorylated at its active site serine, S81, and explored its effects via NMR and MS. Phosphorylation inhibits carbapenemase activity by altering the active site conformation and impeding the carboxylation of an active site lysine, a requirement for class D beta-lactamase activity. The inhibition varies with the carbapenem side chain properties. Phosphorylation-induced chemical shift perturbations extend beyond the active site, suggesting allosteric effects. Our findings offer the first atomic-level insights into the functional consequences of serine phosphorylation of class D beta-lactamases.
引用
收藏
页码:28648 / 28652
页数:5
相关论文
共 50 条
  • [41] Common Clinical Substitutions Enhance the Carbapenemase Activity of OXA-51-Like Class D β-Lactamases from Acinetobacter spp.
    Mitchell, Joshua M.
    Leonard, David A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (11) : 7015 - 7016
  • [42] Molecular dynamics and quantum mechanics analyses of the binding of covalent inhibitor ETX2514 and other analogs to class D β-lactamase OXA-24
    Vega, Camilo Velez
    Durand-Reville, Thomas
    Tommasi, Ruben
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [43] OXA-23 and ISAba1-OXA-66 class D β-lactamases in Acinetobacter baumannii isolates from companion animals
    Ewers, Christa
    Klotz, Peter
    Leidner, Ursula
    Stamm, Ivonne
    Prenger-Berninghoff, Ellen
    Goettig, Stephan
    Semmler, Torsten
    Scheufen, Sandra
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (01) : 37 - 44
  • [44] Distribution of OXA-Type Class D β-Lactamase Genes Among Nosocomial Multi Drug Resistant Acinetobacter baumannii Isolated in Tehran Hospitals
    Karmostaji, Afsaneh
    Peerayeh, Shahin Najar
    Salmanian, Ali Hatef
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2013, 6 (05)
  • [45] OXA-24 Carbapenemase Gene Flanked by XerC/XerD-Like Recombination Sites in Different Plasmids from Different Acinetobacter Species Isolated during a Nosocomial Outbreak
    Merino, Maria
    Acosta, Joshi
    Poza, Margarita
    Sanz, Francisca
    Beceiro, Alejandro
    Chaves, Fernando
    Bou, German
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (06) : 2724 - 2727
  • [46] OXA-134, a Naturally Occurring Carbapenem-Hydrolyzing Class D β-Lactamase from Acinetobacter lwoffii
    Figueiredo, Samy
    Poirel, Laurent
    Seifert, Harald
    Mugnier, Pauline
    Benhamou, Dan
    Nordmann, Patrice
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (12) : 5372 - 5375
  • [47] Activity of the β-Lactamase Inhibitor LN-1-255 against Carbapenem-Hydrolyzing Class D β-Lactamases from Acinetobacter baumannii
    Vazquez-Ucha, Juan Carlos
    Maneiro, Maria
    Martinez-Guitian, Marta
    Buynak, John
    Bethel, Christopher R.
    Bonomo, Robert A.
    Bou, German
    Poza, Margarita
    Gonzalez-Bello, Concepcion
    Beceiro, Alejandro
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (11)
  • [48] A class D β-lactamase clinical variant from Acinetobacter baumannii that possesses an unusually high turnover rate for cephalosporins
    Forbes-Benjamin, Jonika
    June, Cynthia
    Mitchell, Joshua
    Powers, Rachel
    Leonard, David
    PROTEIN SCIENCE, 2017, 26 : 87 - 87
  • [49] Clinical Variants of the Native Class D β-Lactamase of Acinetobacter baumannii Pose an Emerging Threat through Increased Hydrolytic Activity against Carbapenems
    Schroder, Emma C.
    Klamer, Zachary L.
    Saral, Aysegul
    Sugg, Kyle A.
    June, Cynthia M.
    Wymore, Troy
    Szarecka, Agnieszka
    Leonard, David A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (10) : 6155 - 6164
  • [50] In vitro activity of SecA inhibitors in combination with carbapenems against carbapenem-hydrolysing class D β-lactamase-producing Acinetobacter baumannii
    Chiu, Chun-Hsiang
    Liu, Yu-Han
    Wang, Yung-Chih
    Lee, Yi-Tzu
    Kuo, Shu-Chen
    Chen, Te-Li
    Lin, Jung-Chung
    Wang, Fu-Der
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (12) : 3441 - 3448